Key facts
- This page summarizes Postma Robert W.'s Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Jun 2022, 16:35.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer.
Footnote F2
The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
Footnote F3
The option vests in twelve equal monthly installments beginning on July 13, 2022.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney